JAK2 and hepatocellular carcinoma: By prohibiting PD-L1 on the surface of TAMs through blocking Jak2/Stat1 and Jak2/Stat3/c-Myc pathways, TAM-associated PTPRO can prevent T cells from draining in HCC microenvironment (46).